Difference between revisions of "Promethazine"

Revision as of 14:08, 6 July 2010

Promethazine is a first-generation H₁ receptor antagonist of the phenothiazine chemical class used medically as an antihistamine antiemetic. It has a strong sedative effect and in some countries is prescribed for insomnia when benzodiazepines are contraindicated. It is available over the counter in the United Kingdom, Australia, Canada, Switzerland, and many other countries, but by prescription in the United States (brand names Phenergan, Promethegan, Romergan, Fargan, Farganesse, Prothiazine, Avomine, Atosil, Receptozine, Lergigan).^[1]

Chemistry

Chemically, promethazine hydrochloride appears as a white to faint yellow crystlline powder that is practically odorless. Slow oxidation may occur upon prolonged exposure to air usually causing blue discoloration. Promethazine as the hydrochloride salt is freely soluble in water and somewhat soluble in alcohol. Promethazine is a chiral compound, occurring as a mixture of enantiomers (pictured).^[2]

Indications

• As a sedative.^[3]
• For preoperative sedation and to counteract postnarcotic nausea.^[3]
• As antiallergic medication to combat hay fever (allergic rhinitis), etc. To treat allergic reactions it can be given alone or in combination with oral decongestants like pseudoephedrine.^[3]
• As an adjunct treatment for anaphylactoid conditions (IM/IV route preferred).^[3]
• Together with codeine or dextromethorphan against cough.
• As a motion sickness or seasickness remedy when used with Ephedrine or Pseudoephedrine.^[3]
• To combat moderate to severe morning sickness and hyperemesis gravidarum. In the UK promethazine is drug of first choice, being preferred as an older drug with which there is a greater experience of use in pregnancy (second line being metoclopramide or prochlorperazine).^[4]
• Previously it was used as an antipsychotic^[5], although it is generally not administered for this purpose now; promethazine has only approximately 1/10 of the antipsychotic strength of chlorpromazine.
• Also used to potentiate any opiates. Commonly combined with pethidine (AKA, meperidine, or Demerol) in a brand called Mepergan, a meperidine/promethazine combination. Also frequently used in conjunction with codeine, in a syrup form. The combination leads to more powerful euphoric effects than with codeine alone.

Mechanism of action

• Promethazine is a phenothiazine derivative that competitively blocks histamine H₁ receptors without blocking the secretion of histamine. It also is a very weak dopamine antagonist.^[6]
• It has sedative, anti-motion-sickness, anti-emetic, and anti-cholinergic effects.^{[citation needed]}

Side effects

Some common side effects include:

• Confusion in the elderly
• Drowsiness, dizziness, fatigue, more rarely vertigo
• Dry mouth
• Respiratory depression in patients under age of 2 and in those with severely compromised pulmonal function
• Constipation
• Chest Discomfort/Pressure. (typically in cases when patient is already taking medication for high blood pressure)
• Euphoria (very rare, except with high IV doses and/or coadministration with opioids/CNS depressants)
• Restless legs ^[7]
• Paresthesia
• Short temper/Irritability

Extremely rare side effects include:

• Seizures
• Neuroleptic malignant syndrome

IV administration: Dilute with 0.9% NaCl or D5W. CONCENTRATION: Doses should not exceed a concentration of 25mg/ml. Administer through a large-bore vein through a running IV line into the most distal port. Slight yellow color does not alter potency. Do not administer if precipitate is present. RATE: Administer each 25mg slowly, over at least 10-15min. Rapid administration may produce a transient fall in blood pressure. ^[8] Serious complications including those listed above have resulted from improper parenteral administration, including those requiring surgical intervention and amputation.

Because of potential for more severe side effects, this drug is on the list to avoid in the elderly. (See NCQA’s HEDIS Measure: Use of High Risk Medications in the Elderly).

Laboratory examinations

All patients should have their blood pressure measured frequently. During long-term therapy, blood cell counts, liver function studies, EKG, and EEG are recommended. The intervals should be determined according to the risk profile of the patient. In high doses, promethazine can create auditory and visual hallucinations causing panic and intense fear.^{[citation needed]}

Case law

The U.S. Supreme Court accepted a case involving promethazine that influences product liability. Diana Levine, a woman suffering from a migraine, was administered Wyeth's Phenergan via IV push. The drug was injected improperly resulting in gangrene and subsequent amputation of her right forearm below the elbow. A state jury awarded her $6 million in punitive damages. The case was appealed to the Supreme Court on grounds of federal preemption and substantive due process.^[9] The Supreme Court upheld the lower courts' rulings stating that "Wyeth could have unilaterally added a stronger warning about IV-push administration" without acting in opposition to federal law.^[10] In effect, this means that drug manufacturers can be held liable for injuries if the FDA-approved warnings of potential adverse affects is deemed insufficient by state courts. On September 9 2009 the US FDA made the decision that a black box warning for injection be put on promethazine stating the contraindication for subcutaneous administration. The preferred administrative route is intramuscular (IM) which reduces risk of surrounding muscle and tissue damage ^[11]

References

External links

• "Promethazine". U.S. National Library of Medicine and National Institutes of Health. 

fr:Prométhazine it:Prometazina ka:პიპოლფენი hu:Prometazin nl:Promethazine ja:プロメタジン nn:Prometazin pl:Prometazyna pt:Prometazina ru:Прометазин fi:Prometatsiini sv:Prometazin th:โปรเมทาซีน

1. ↑ RxList: Promethazine
2. ↑ http://www.rxlist.com/cgi/generic/phenergan.htm RxList: Promethazine Description
3. ↑ ^{3.0 3.1 3.2 3.3 3.4} RxList Indications for Promethazine
4. ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
5. ↑ [1]
6. ↑ David J. McCann and Brett Roth, Toxicity, Antihistamine, eMedicine Toxicology, updated June 21, 2007
7. ↑ Cordingley Neurology
8. ↑ Davis Drug Guide for Nurses Eleventh Edition pgs. 1017-1020
9. ↑ Liptak, Adam (2008-09-18). "Drug Label, Maimed Patient and Crucial Test for Justices". The New York Times. Retrieved 2008-10-31. 
10. ↑ Stout, David (2009-03-04). "Drug Approval Is Not a Shield From Lawsuits, Justices Rule". The New York Times. Retrieved 2009-03-04. 
11. ↑ http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm182169.htm